
Revolutionary Gene Therapy Treats Age-Related and Genetic Hearing Loss
Researchers at Mass Eye and Ear have successfully used adeno-associated virus vectors in gene therapies to treat genetic hearing loss in aged mouse models, pointing to the potential of virally mediated gene therapies for treating genetic hearing loss in the aged population. By 2050, one in 10 individuals is expected to live with some form of hearing loss, and genetic hearing loss is often the most difficult to treat. The breakthrough suggests that a virally mediated gene therapy could potentially treat genetic hearing loss, either by itself or in combination with a cochlear implant.


